Complement Activation, Immunogenicity, and Immune Suppression as Potential Side Eff ects of Liposomes - Harnessing Biomaterials in Nanomedicine: Preparation, Toxicity, and Applications - page 332

71. Okada, N., Yasuda, T., Tsumita, T., and Okada, H. (1983).
Membrane sialoglycolipids regulate the activation of
alternative complement pathway by liposomes containing
trinitrophenylaminocaproyldipalmitoylphosphatidylethaolamine.
Immunology 48, pp. 129-140.
72. Ozato, K., Ziegler, H. K., and Henney, C. S. (1978). Liposomes as
model membrane systems for immune attack. II. The interaction of
complement and K cell populations with immobilized liposomes. J.
Immunol . 121, pp. 1383-1388.
73. Pedersen, M. B., Zhou, X., Larsen, E. K. U., Sorensen, U. S., Kjems, J.,
Nygaard, J. V., Nyengaard, J. R., Meyer, R. L., Boesen, T., and Vorup-
Jensen, T. (2010). Curvature of synthetic and natural surfaces is an
important target feature in classical pathway complement activation.
J. Immunol . 184, pp. 1931-1945.
74. Richards, R. L., Habbersett, R. C., Scher, I., Janoff , A. S., Schieren, H. P.,
Mayer, L. D., Cullis, P. R., and Alving, C. R. (1986). Influence of vesicle size
on complement-dependent immune damage to liposomes. Biochim.
Biophys. Acta 855, pp. 223-230.
75. Richardson, D. S., Kelsey, S. M., Johnson, S. A., Tighe, M., Cavenagh, J. D.,
and Newland, A. C. (1997). Early evaluation of liposomal daunorubicin
(DaunoXome, Nexstar) in the treatment of relapsed and refractory
lymphoma. Invest. New Drugs 15, pp. 247-253.
76. Sculier, J. P., Coune, A., Brassinne, C., Laduron, C., Atassi, G., Ruysschaert,
J. M., and Fruhling, J. (1986). Intravenous infusion of high doses of
liposomes containing NSC 251635, a water-insoluble cytostatic agent.
A pilot study with pharmacokinetic data. J. Clin. Oncol . 4, pp. 789-797.
77. Solomon, R., and Gabizon, A. (2008). Clinical pharmacology of
liposomal anthracyclines: Focus on pegylated liposomal doxorubicin.
Clin. Lymphoma Myeloma 8, pp. 21-32.
78. Sou, K., and Tsuchida, E. (2008). Electrostatic interactions and
complement activation on the surface of phospholipid vesicle
containing acidic lipids: eff ect of the structure of acidic groups. Biochim.
Biophys. Acta 1778, pp. 1035-1041.
79. Storm, G., ten Kate, M. T., Working, P. K., and Bakker-Woudenberg, A.
(1998). Doxorubicin entrapped in sterically stabilized liposomes:
eff ects on bacterial blood clearance capacity of the mononuclear
phagocyte system. Clin. Cancer Res . 4, pp. 111-115.
80. Szebeni, J. (1998). The interaction of liposomes with the complement
system. Crit. Rev. Ther. Drug Carrier Syst . 15, pp. 57-88.